Best Mycophenolate Mofetil Tablets in India - Mycophenolate Mofetil (MMF) serves as a fundamental treatment method in the specialized field of transplant medicine, which includes both nephrology and transplant procedures. The medication serves two purposes because it prevents organ rejection in patients who undergo kidney, heart, or liver transplants, while doctors also use it to treat autoimmune diseases such as Lupus Nephritis. The immunosuppressant functions as an enzyme blocker, which prevents T and B lymphocyte development; therefore, the MMF brand choice needs to meet high standards of quality and bioavailability because it will determine health results throughout your life.
The guide offers a comprehensive examination of Mycophenolate Mofetil brands that people trust the most in India during 2026, while it specifically examines research-based products created by Canbro Nephrology and Urology Care.
10 Best Mycophenolate Mofetil Tablets in India
1. MOFELAST-500 (Canbro Nephrology and Urology Care)
Canbro Nephrology and Urology Care is a prominent leader in the renal and urological segment in India, and its contribution to the healthcare system is immense. Our Mycophenolate Mofetil formulated tablet, named MOFELAST-500, is designed under high precision facilities and following every crucial regulator and protocol of the WHO-GMP that ensures its product safety and quality. It is primarily used in transplant patients to prevent organ rejection.
Why MOFELAST-500 is the Preferred Clinical Choice?
MOFELAST-500, containing Mycophenolate Mofetil in its formulation, is designed to provide consistent drug release, ensuring stable plasma concentrations of mycophenolic acid. The manufacturing process ensures that the 500mg dose is absorbed efficiently, reducing the risk of sub-therapeutic levels that could lead to graft rejection.
As a company dedicated to nephrology, Canbro understands the delicate balance required for post-transplant immunosuppression better than multi-specialty brands. It is produced in WHO-GMP certified facilities, and every batch of MOFELAST-500 undergoes rigorous stability testing to withstand India’s varied climatic conditions.
The tablets are housed in premium moisture-resistant Alu-Alu packs to prevent chemical degradation, which maintains the stability of our tablets and maintain its shelf life for the long term.
MOFELAST-500 tablet can be used to minimize the common GI side effects associated with MMF, such as nausea and diarrhea, improving patient compliance.
Canbro ensures that MOFELAST-500 is accessible through a highly reliable supply chain, ensuring patients never miss a critical dose and is widely recognized by leading nephrologists for its role in maintaining graft survival and managing complex autoimmune renal disorders.
2. Mycofit (Intas Pharmaceuticals Ltd.)
Mycofit tablet is one of the most widely prescribed MMF brands in the Indian private healthcare sector, known for its strong clinical data backing its use in renal transplant recipients.
Their products are manufactured in Intas’s global-standard facilities with high purity levels and maintain strict adherence to international safety and pharmacovigilance standards.
It is available in various strengths to allow for precise dosage titration and features a rapid-dissolve coating to aid in efficient drug absorption, which makes it frequently used in institutional supply chains due to its established reliability.
3. Cellmune (Cipla Ltd.)
Cipla’s entry into the transplant segment is marked by high affordability and trust and features an "Easy-to-Swallow" design to assist patients on multi-drug regimens.
Cellmune tablet ensures consistent drug delivery, reducing the frequency of "peak and trough" levels, which is commonly prescribed for pediatric transplant patients under specialist supervision and is backed by Cipla’s extensive research in the field of immunology.
It is widely available across both urban and rural pharmacy networks and is popular as Cipla follows eco-friendly manufacturing practices without compromising on tablet integrity.
4. Renodapt (Biocon India Ltd.)
Biocon is a pioneer in biologics and immunology, making Renodapt a technologically advanced brand that is preferred by many government and corporate hospitals for long-term maintenance therapy.
It focuses on the long-term management of chronic rejection in transplant patients and is known for its high stability at room temperature, which is essential for Indian climates.
Biocon India utilizes high-grade Active Pharmaceutical Ingredients (APIs) for maximum potency, which are subjected to rigorous bioequivalence studies compared to the innovator molecule.
The brand provides clear, professional documentation for physicians regarding drug interactions.
5. Fenograf (Torrent Pharmaceuticals Ltd.)
Torrent Pharma’s specialty division ensures Fenograf meets niche therapeutic requirements, which is highly effective in preventing acute rejection episodes in the early post-operative phase.
It features a sophisticated coating technology to protect the drug from stomach acid and is recognized for its consistent dissolution profile in various metabolic environments.
The brand is backed by Torrent’s long history of excellence in chronic disease management, which consistently ranks high in patient satisfaction due to minimal side-effect profiles.
It offers high value-for-money without sacrificing ingredient purity, and due to this, it is widely prescribed by healthcare professionals to prevent organ rejection in patients receiving kidney, heart, or liver transplants.
6. Mofilet (BSM Health Care)
The Mofilet tablet, the Mcophenolate Mofetil brand, is a rising name in the nephrology segment, focusing on targeted immunosuppression, which is formulated to provide an immediate release of mycophenolic acid for quick action.
It is manufactured in facilities that focus on high-precision chemical engineering and is regularly updates formulations to match the latest DCGI safety guidelines.
The brand provides a cost-effective alternative for patients on lifelong immunosuppressant therapy. BSM Health Care offers secure, tamper-proof packaging to ensure safety, gaining traction among distributors due to its reliable market supply.
7. Mycomune (Zydus Lifesciences)
Zydus Lifesciences utilizes advanced pharmaceutical aesthetics and high-purity salts, and its Mycophenolate Mofetil brand, named Mycomune, is trusted for its role in preventing the proliferation of rejection-causing cells.
The medication undergoes multi-level safety checks before reaching the pharmacy shelf, which features clear dosage instructions and patient education leaflets within the pack.
It is known for its high compatibility when used alongside tacrolimus or cyclosporine and is a preferred choice for many clinical trials in India due to its standardized quality.
Zydus’s extensive distribution network ensures that Mycomune is rarely out of stock.
8. Ipca MMF (Ipca Laboratories)
Ipca is known for its vertical integration, controlling the quality from raw salt to the final tablet, and is also recognized for its high degree of safety in long-term autoimmune therapy.
Ipca MMF is highly stable and resistant to environmental fluctuations.
It focuses on providing consistent therapeutic outcomes for heart and liver transplant cases and maintains a strict "Zero-Defect" manufacturing policy across its units.
The Ipca MMF tablet offers excellent clinical support and information for healthcare providers, due to which it is one of the most cost-efficient options for large-scale institutional indents.
9. Mycept 500 mg Tablet (Pancea Biotec Ltd.)
Panacea Biotec is a specialist in vaccines and transplant medicine, bringing unique expertise, and its Mycept tablet containing Mycohenolate Mofetil is formulated using advanced drug delivery systems for optimized absorption.
It features a high-grade enteric coating to protect the active salt until it reaches the intestine, backed by significant investments in R&D specifically for transplant success.
The medication is known for its high degree of shelf-life stability even in humid coastal regions and is one of the most highly recommended for patients who have shown sensitivity to other MMF brands.
Along with therapeutic medications, Panacea Biotec Ltd. provides a professional detailing kit to help doctors monitor patient progress.
10. CellCEPT (Roche Products India Pvt. Ltd.)
Roche Products India Pvt. Ltd. is the original innovator brand that defined the global standard for Mycophenolate Mofetil, which is manufactured under the highest global pharmaceutical standards of Roche.
The mediation is backed by the most extensive clinical trial database in the history of transplant medicine and provides maximum safety assurance regarding long-term side effects and outcomes.
The "Reference Product" against which all other generic versions are measured.
It is often the first choice for complex or high-risk transplant cases, and it features the most advanced pharmacological profile in the MMF therapeutic segment.
Frequently Asked Questions
Q: How does the MOFELAST-500 tablet work, and what makes its absorption profile differ from that of generic MMF tablets?
A: The medication is designed to provide consistent bioavailability and ensure the drug level in your blood remains stable, which makes it critical for preventing organ rejection.
Q: Can I switch to other Mycophenolate Mofetil tablet brands from the brand that was prescribed to me, if it does not work effectively?
A: No, it should be only done under medical supervision, and if only a healthcare professional allows you to do so, as the medication may take time, and changing the brand may alter the composition and drug level, which may cause alteration in your condition and may cause several side effects.
A: MMF has a specific half-life, and taking it exactly 12 hours apart ensures a consistent therapeutic level of the medication remains in the body to prevent organ rejection, leaving no time for the immune system to react.
Q: Do I need to place the MOFELST-500 tablet under special storage conditions to keep its stability and shelf life maintained even in the Indian hot climate?
A: It requires the same storage conditions as other medication required like, keep the medication in its original Alu-Alu packaging and keeping it away from direct sunlight exposure to maintain its stability and shelf life.
Q: Can a pregnant and lactating woman take Mycophenolate Mofetil tablet?
A: No, it should be strictly prohibited for pregnant and breastfeeding women, as there are several high risks of birth defects associated with MMF. It should be taken only under medical guidance and only if it is prescribed by a qualified healthcare professional.
Q: Why do healthcare professionals prefer MMF over older immunosuppressants like Azathioprine during organ rejection?
A: Due to the selective nature of MMF to target specific immune cells during organ rejection, which often results in fewer side effects and better graft survival than older immunosuppressants like Azathioprine.
